Abstract
Cato et al. utilize cistrome and transcriptome analyses in castration-resistant prostate cancer (CRPC) to reveal that the androgen receptor (AR) splice variant ARv7 functions as a transcriptional repressor and heterodimerizes with full-length AR at a subset of growth-suppressive genes to support CRPC growth.
Original language | English (US) |
---|---|
Pages (from-to) | 401-413.e6 |
Journal | Cancer cell |
Volume | 35 |
Issue number | 3 |
DOIs | |
State | Published - Mar 18 2019 |
Keywords
- AR variant v7 (ARv7)
- androgen receptor (AR)
- castration-resistant prostate cancer (CRPC)
- transcription
ASJC Scopus subject areas
- Oncology
- Cancer Research